By Julie Steenhuysen CHICAGO (Reuters) - Clear evidence this week that Eisai and Biogen (NASDAQ:BIIB)'s drug lecanemab slows cognitive decline in early stage dementia has...
By Deena Beasley, Julie Steenhuysen and Rocky Swift (Reuters) - An experimental Alzheimer's drug made by Eisai Co (OTC:ESALY) Ltd and Biogen (NASDAQ:BIIB) slowed cognitive and...
Let's be frank: The third quarter was a mess for stocks. It doesn't much matter where the stocks were traded, except this: U.S. stocks in September were not a place you wanted to...
Well, let’s just take a moment today and say one final goodbye to September. Here’s your hat, and there’s the door. The past month saw stocks on a downward tear...
As we move into October soon, I wanted to take a moment to highlight some of my recent daily columns from September. I wrote a Daily titled Why Higher Inflation Matters and...
Biogen Inc. is a global biopharmaceutical company. It is focused on discovering, developing and delivering therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis. It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions; RITUXAN HYCELA for the treatment of non-Hodgkin's lymphoma and CLL; GAZYVA; OCREVUS; and other potential anti-CD20 therapies, including mosunetuzumab.
| Average | 268.72 (+2.69% Upside) |
| High | 360 |
| Low | 190 |
| Price | 261.69 |
| No. of Analysts | 32 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Buy | Buy | Buy |
| Technical Indicators | Sell | Sell | Strong Sell | Strong Buy | Sell |
| Summary | Strong Sell | Sell | Neutral | Strong Buy | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 240.81 | 246.67 | 233.27 | -8.63 | -3.46% | 85.91M | NASDAQ | |||
| 15.34 | 15.47 | 14.91 | +0.070 | +0.46% | 183.21K | NASDAQ | |||
| 90.77 | 91.75 | 90.07 | -0.75 | -0.82% | 907.57K | NASDAQ | |||
| 17.96 | 18.59 | 17.94 | -0.77 | -4.11% | 403.98K | NASDAQ | |||
| 236.35 | 242.66 | 234.56 | -9.17 | -3.73% | 453.42K | NYSE | |||
| 34.94 | 35.09 | 33.59 | +0.85 | +2.49% | 1.49M | NYSE | |||
| 8.70 | 8.72 | 8.22 | -0.02 | -0.23% | 9.27M | NYSE | |||
| 66.17 | 68.12 | 65.35 | -0.30 | -0.45% | 6.32M | NASDAQ | |||
| 236.73 | 241.59 | 227.38 | -4.01 | -1.67% | 10.69M | NASDAQ | |||
| 26.39 | 26.98 | 25.43 | -1.21 | -4.38% | 2.97M | NYSE | |||
| 44.12 | 44.37 | 43.68 | -0.34 | -0.76% | 14.98M | NYSE | |||
| 15.90 | 15.96 | 15.44 | -0.15 | -0.93% | 25.50M | NYSE | |||
| 16.04 | 16.68 | 15.64 | -0.69 | -4.12% | 39.49M | NYSE | |||
| 56.24 | 56.65 | 55.51 | -0.54 | -0.95% | 14.10M | NYSE | |||
| 90.91 | 91.62 | 88.64 | +1.00 | +1.11% | 2.29M | NASDAQ |